Quick Comparison

ALCARNAC (N-Acetyl Cysteine)
Half-Life4-5 hours5.6 hours
Typical DosageStandard: 500-2000 mg daily in 1-2 doses. For cognitive support: 1000-2000 mg daily. For neuropathy: 1500-3000 mg daily. Take in the morning — may be mildly stimulating.Standard: 600-1800 mg daily in 2-3 divided doses. For psychiatric applications: 1200-2400 mg daily (under medical supervision). Take on an empty stomach for best absorption. Can cause nausea — take with a small amount of food if needed.
AdministrationOral (capsules, powder). Well-absorbed on an empty stomach.Oral (capsules, powder). Take on empty stomach or with light food. Effervescent tablets also available.
Research Papers9 papers10 papers
Categories

Mechanism of Action

ALCAR

ALCAR crosses the blood-brain barrier via the organic cation transporter (OCTN2) more effectively than L-carnitine. In neurons, it is hydrolyzed by carnitine acetyltransferase to donate its acetyl group to coenzyme A, forming acetyl-CoA—which can then be used for acetylcholine synthesis via choline acetyltransferase, effectively providing raw material for the memory neurotransmitter. ALCAR also transports long-chain fatty acids across the inner mitochondrial membrane via the carnitine palmitoyltransferase system for beta-oxidation and ATP production. ALCAR activates nerve growth factor (NGF) signaling, possibly through modulation of NGF receptor (TrkA) expression or downstream MAPK/ERK pathways. It has antioxidant properties, reducing lipid peroxidation in mitochondrial membranes and scavenging free radicals. These mechanisms support cognitive function and neuroprotection.

NAC (N-Acetyl Cysteine)

NAC provides cysteine, the rate-limiting substrate for glutathione (GSH) synthesis via gamma-glutamylcysteine ligase (GCLC) and glutathione synthetase (GSS). GSH is the primary intracellular antioxidant, essential for GPx and GST-mediated detoxification of reactive oxygen species in neurons. NAC also modulates glutamate via the cystine-glutamate antiporter (System Xc-, composed of xCT and 4F2hc) — NAC is deacetylated to cysteine, which exchanges for glutamate; the increased extracellular cystine is reduced to cysteine intracellularly, while the exchange increases extrasynaptic glutamate, which activates inhibitory mGlu2/3 autoreceptors on presynaptic terminals, reducing excessive glutamatergic signaling and compulsive behaviors. This glutamate modulation is the basis for psychiatric applications (OCD, addiction). NAC may also directly modulate NMDA receptors via redox sites.

Risks & Safety

ALCAR

Common

Nausea, fishy body odor, restlessness, gastrointestinal discomfort.

Serious

May increase agitation in Alzheimer's patients. TMAO production may be a cardiovascular concern with chronic high doses.

Rare

Seizures in susceptible individuals, increased thyroid activity.

NAC (N-Acetyl Cysteine)

Common

Nausea, diarrhea, unpleasant sulfur smell/taste.

Serious

May be harmful in certain contexts — there is concern it could protect cancer cells from oxidative stress. May interact with nitroglycerin (dangerous blood pressure drop).

Rare

Bronchospasm in asthmatics (when inhaled).

Full Profiles